Levi Strauss & Co. vs 22nd Century Group Inc — how do they compare? Levi Strauss & Co. trades at $22.8 (market cap $8.75B), while 22nd Century Group Inc trades at $4.33 (market cap $1.52M). The key difference: Levi Strauss & Co. is far larger — about 5756.6× 22nd Century Group Inc's market cap, and Levi Strauss & Co. pays a 2.81% dividend while 22nd Century Group Inc pays none. Which is the better fit depends on your goals.
| LEVI | XXII | |
|---|---|---|
Market Cap | $8.75B | $1.52M |
Sector | Consumer Cyclical | Technology |
52-Week High | $25.53 | $801.00 |
52-Week Low | $17.92 | $3.72 |
Enterprise Value | $10.07B | -$6.71M |
Dividend Yield | 2.81% | — |
Signals from Pluang's Aura AI — not financial advice
Levi Strauss (LEVI) trades at $22.47, down 4.75% today, but maintains strong fundamentals with a P/E of 16.24 and robust profitability metrics including 61.72% gross margin and 29.31% ROE. The company has beaten earnings estimates for three consecutive quarters and recently raised its dividend. Technical indicators show mixed signals with bearish moving averages but oversold RSI conditions, while analyst consensus remains strongly bullish with a $27.88 price target.
LEVI presents a compelling value opportunity with consistent earnings outperformance and digital transformation progress, though recent cybersecurity concerns and tariff pressures create near-term headwinds. The stock's current valuation discount to analyst targets and strong DTC growth strategy support upside potential, but investors should monitor execution risks and market volatility.
22nd Century Group (XXII) trades at $4.31, down 0.92% on the day, with a neutral technical signal and bearish moving averages. The company shows deep unprofitability with a gross margin of -52.19% and net margin of -65.76%, though revenue was $7.05M in 2025. Recent corporate actions include a 20:1 reverse stock split in June 2026, and news highlights retail expansion for VLN reduced-nicotine cigarettes in California and New York.
The outlook remains speculative with high execution risk amid persistent losses, but analyst sentiment is bullish with 75% buy ratings. Key risks include negative cash flow from operations, regulatory hurdles for tobacco products, and the need for successful commercialization of VLN to achieve profitability.
Trailing returns across standard periods
Levi Strauss & Co is involved in designing, marketing, and selling products that include jeans, casual and dresses pants, tops, shorts, skirts, jackets, footwear, and related accessories directly or through third parties and licensees for men, women, and children under Levi's, Dockers, Signature by Levi Strauss & Co. and Denizen brands. The company manages its business according to three regional segments: the Americas, which is the key revenue driver
Read more on LEVI →22nd Century Group is a plant biotechnology company that uses genetic engineering and gene editing to control the levels of nicotine in tobacco plants. Its flagship product line, VLN®, is the first and only combustible cigarette authorized by the FDA as a Modified Risk Tobacco Product (MRTP), containing 95% less nicotine than traditional cigarettes to help adult smokers smoke less.
Read more on XXII →